Geraldine Zimmer-Bensch | Neuroepigenetics | Best Researcher Award

Prof. Geraldine Zimmer-Bensch | Neuroepigenetics | Best Researcher Award

Prof. Geraldine Zimmer-Bensch | RWTH Aachen University | Germany

Prof. Dr. Geraldine Zimmer-Bensch is a distinguished neuroepigeneticist at RWTH Aachen University, Germany. With over two decades of academic and research excellence, she has significantly contributed to understanding how epigenetic mechanisms influence brain development and disorders. Her research spans neuronal migration, cortical circuit formation, and neurodevelopmental diseases. She earned her PhD under Prof. Jürgen Bolz in Jena, followed by impactful postdoctoral stints, including one with Prof. Roberto Lent in Rio de Janeiro. As an editor for high-impact journals and collaborator on international projects, she remains a key voice in neuroepigenetics. Prof. Zimmer-Bensch’s research not only advances fundamental neuroscience but also provides translational insights into conditions such as schizophrenia and neurodegeneration. Through interdisciplinary approaches and global collaborations, she exemplifies academic leadership and innovation in modern neuroscience.

Publication Profiles: 

Google Scholar 
Orcid

Education:

Prof. Geraldine Zimmer-Bensch began her academic journey with a diploma in Biology from the University of Jena. She pursued her PhD in Neurobiology at the same institution under the mentorship of Prof. Jürgen Bolz. Her doctoral research focused on molecular and cellular mechanisms guiding interneuron development. She then expanded her training with postdoctoral research in neurodevelopment at the University of Jena and the Federal University of Rio de Janeiro under Prof. Roberto Lent, exploring neural migration and guidance cues in developing brain structures. This robust educational background laid the foundation for her expertise in epigenetics and neurodevelopment. Her interdisciplinary education across molecular biology, neuroanatomy, and epigenetics equips her to address complex neuroscientific questions at the intersection of genomics and brain function, contributing to groundbreaking insights into brain evolution, neural plasticity, and neuropsychiatric disorders.

Experience:

Prof. Dr. Zimmer-Bensch has held a professorship in Neuroepigenetics at RWTH Aachen University. Prior to this, she led a research group at the Institute of Human Genetics, University Hospital Jena, where she conducted seminal research on epigenetic mechanisms in neuronal development. Her postdoctoral experience includes prestigious positions in Jena and Brazil, where she worked with leading scientists on neural migration and brain structure formation. She is currently involved in several interdisciplinary collaborations across Europe and Asia, including research on brain-gut interactions, electrophysiology, microscopy, and computational modeling. As Editor-in-Chief of Neurogenetics and topic editor for multiple high-impact journals, she actively shapes scientific discourse in her field. Her mentoring, leadership, and ability to integrate cross-disciplinary methodologies make her a standout scientist in neuroepigenetics. Her work bridges basic and translational neuroscience, with applications in understanding developmental disorders, psychiatric conditions, and age-related cognitive decline.

Research Focus:

Prof. Zimmer-Bensch’s research centers on the epigenetic regulation of brain development and function, particularly focusing on cortical interneuron migration, neuronal integration, and circuit maturation. She investigates how DNA methylation and histone modifications orchestrate the formation and plasticity of cortical networks, with a special focus on DNMT1’s non-canonical roles. Her studies reveal how disruptions in epigenetic control mechanisms may lead to neurodevelopmental disorders, psychiatric conditions, and neurodegeneration. Recent projects explore the brain-gut axis in anxiety, sex-specific epigenetic vulnerabilities, and computational models of synaptic regulation. Utilizing cutting-edge tools like microfluidics, microscopy, molecular simulations, and electrophysiology, her work is highly interdisciplinary. Through collaborations with institutions across Germany, France, Switzerland, Japan, and India, her lab contributes to both mechanistic insights and potential therapeutic pathways for brain diseases. Her future research aims to integrate multi-omics approaches to uncover novel targets for neuropsychiatric and neurodegenerative therapies.

Publications Top Notes: 

  1. A hereditary spastic paraplegia mouse model supports a role of ZFYVE26/SPASTIZIN for the endolysosomal system – PLoS Genetics

  2. Emerging roles of long non-coding RNAs as drivers of brain evolution – Cells

  3. Ephrin‐A5 acts as a repulsive cue for migrating cortical interneurons – European Journal of Neuroscience

  4. A spastic paraplegia mouse model reveals REEP1-dependent ER shaping – The Journal of Clinical Investigation

  5. The epigenome in neurodevelopmental disorders – Frontiers in Neuroscience

  6. Bidirectional ephrinB3/EphA4 signaling mediates interneuron segregation in the migratory stream – Journal of Neuroscience

  7. Chondroitin sulfate and semaphorin 3A guide tangential interneuron migration – Cerebral Cortex

  8. Ephrins guide migrating cortical interneurons in the basal telencephalon – Cell Adhesion & Migration

  9. EphA/ephrin A reverse signaling promotes migration of cortical interneurons – Development

  10. Multiple effects of ephrin-A5 on cortical neurons mediated by SRC kinases – Journal of Neuroscience

Conclusion:

Prof. Dr. Geraldine Zimmer-Bensch is an exceptional researcher with a consistent record of high-impact contributions to neuroscience and epigenetics. Her ability to conduct pioneering research, lead international collaborations, and steer academic publishing speaks volumes about her expertise and influence. While there is scope for expanding into translational domains, her foundational work has laid critical groundwork for future therapeutic strategies in neurodevelopmental and neuropsychiatric disorders. Given her scientific rigor, leadership, and international collaborations, she is eminently suitable for the Best Researcher Award. Recognizing her achievements would not only honor her individual excellence but also spotlight the growing importance of neuroepigenetics in contemporary biomedical science.

Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Naoki Harada, Osaka Metropolitan University, Japan

Naoki Harada is an Associate Professor at Osaka Metropolitan University, Japan, with extensive expertise in molecular biology, biochemistry, endocrinology, and nutrition. He earned his Ph.D. in Life Sciences from Osaka Prefecture University in 2007. Over the past two decades, Harada has made significant contributions to understanding the physiological and biochemical mechanisms underpinning metabolic diseases, particularly type 2 diabetes. His research, characterized by high citation impact (H-index of 25), centers on pancreatic β-cell function and metabolic regulation. He has published 77 peer-reviewed articles and holds a patent related to therapeutic interventions. Harada has collaborated with leading scientists like Professors Hiroshi Inui and Ryoichi Yamaji, strengthening his academic footprint in both national and international circles. A member of multiple scientific societies, Harada continues to influence the field through impactful research, industry collaboration, and educational leadership.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Consistent Research Output

    • 77 peer-reviewed publications in reputable journals (SCI, Scopus).

    • Recent high-impact studies published in Journal of Biological Chemistry, Scientific Reports, and FASEB BioAdvances.

    • Active research profile with an H-index of 25 and over 1,785 citations.

  2. Innovative Scientific Contributions

    • Identified REDD2 as a novel therapeutic target for type 2 diabetes—bridging basic research with translational medicine.

    • Works across disciplines such as molecular biology, endocrinology, and nutritional biochemistry.

  3. Project Leadership & Industry Engagement

    • Led or participated in 14 major research projects.

    • 5 consultancy/industry-based projects, reflecting application-oriented research.

  4. Academic and Collaborative Network

    • Strong academic collaborations with Professors Hiroshi Inui and Ryoichi Yamaji.

    • Member of prestigious scientific societies (e.g., Japanese Biochemical Society, Japan Society of Nutrition and Food Science).

  5. Scientific Versatility

    • Contributions span fundamental mechanisms (e.g., oxidative stress, insulin signaling) to dietary interventions (e.g., mogrol, oleamide).

    • Demonstrates ability to bridge molecular insights with systemic physiological outcomes.

⚙️ Areas for Improvement:

  1. International Visibility and Engagement

    • Expanding participation in international conferences and editorial boards could elevate his global scientific standing.

    • Pursuing cross-border collaborations would further enrich the translational value of his work.

  2. Commercialization and Patent Activity

    • While one patent is noted, increased focus on intellectual property development and biomedical commercialization could further validate his applied research strength.

  3. Outreach and Communication

    • More active public science communication (e.g., webinars, policy advocacy, media coverage) would amplify the societal impact of his research.

🎓 Education:

Naoki Harada received his Ph.D. in Life Sciences from Osaka Prefecture University, Osaka, Japan, in September 2007. His doctoral studies laid the foundation for his interdisciplinary research in molecular biology, biochemistry, and endocrinology. Harada’s academic path was driven by a keen interest in the cellular and molecular mechanisms underlying metabolic regulation, particularly in relation to glucose homeostasis and pancreatic function. His education provided him with a solid grounding in experimental techniques, critical thinking, and scientific communication, which have become hallmarks of his later work. The institution, known for excellence in biosciences, enabled Harada to cultivate a strong research acumen. His academic training was complemented by exposure to applied research, linking basic science with clinical and nutritional applications—an approach that he has continued to emphasize throughout his career. His strong educational background plays a pivotal role in his current research endeavors and professional development.

💼 Experience:

Dr. Naoki Harada began his academic career in 2008 as an Assistant Professor at the Graduate School of Life and Environmental Sciences, Osaka Prefecture University. He was promoted to Lecturer in 2015, and subsequently to Associate Professor in 2019. Since 2022, he has served as Associate Professor at the Graduate School of Agriculture, Osaka Metropolitan University. Harada has consistently combined teaching with intensive research, mentoring graduate students while advancing his lab’s focus on metabolic diseases and endocrine physiology. His experience includes leading 14 research projects, consulting on 5 industry-linked nutrition initiatives, and co-authoring over 75 scientific papers. His experience reflects a blend of academic leadership, scientific innovation, and multidisciplinary collaboration. Notably, Harada’s role in identifying REDD2 as a therapeutic target exemplifies his contribution to translational science. He maintains strong academic partnerships and actively contributes to several professional societies, making him a respected figure in Japan’s scientific community.

🔬 Research Focus:

Naoki Harada’s research is at the intersection of molecular biology, endocrinology, and nutrition science, with a particular focus on pancreatic β-cell physiology and glucose metabolism. He investigates how oxidative stress, hormonal signals, and metabolic regulators influence insulin secretion and β-cell viability. One of his pivotal contributions is identifying the REDD2 gene as a negative regulator of β-cell function, offering novel therapeutic targets for type 2 diabetes mellitus. His studies also explore nutrient-sensing pathways, G-protein-coupled receptors, and hormonal modulation of energy metabolism. Harada’s recent work delves into the effects of dietary compounds like mogrol and oleamide on metabolic health, linking molecular mechanisms to real-world dietary interventions. His ability to bridge bench science with clinical and nutritional applications sets his research apart. Through collaborations with leading experts and high-impact publications, Harada continues to advance knowledge in the prevention and treatment of metabolic disorders.

📚 Publications Top Notes:

  • 🧬 REDD2 confers pancreatic β-cell dysfunction in high-fat diet-fed miceJournal of Biological Chemistry, 2025

  • 🦷 Androgens suppress ST3GAL1/4, modulating mucin glycosylation and microbiota in miceBioscience, Biotechnology, and Biochemistry, 2025

  • 🍟 CRTC1 in MC4R cells regulates dietary fat intakeFASEB BioAdvances, 2024

  • 💉 Insulin reduces ER stress-induced apoptosis in INS-1 β-cellsPhysiological Reports, 2024

  • 🍬 Mogrol activates GPBAR1 and insulin secretion, alleviates hyperglycemiaScientific Reports, 2024

  • 🔥 Androgen receptor suppresses β-adrenoceptor-mediated thermogenesisJournal of Biological Chemistry, 2022

  • 🏥 Age-dependent sex differences in NAFLD in TSOD and db/db micePLOS ONE, 2022

  • 🐭 Dietary oleamide attenuates obesity in caged miceBioscience, Biotechnology, and Biochemistry, 2022

  • 🌿 Curcumin targets GPR55 receptornpj Science of Food, 2022

  • 💪 Oleamide rescues muscle atrophy in small-caged miceBritish Journal of Nutrition, 2021

🧾 Conclusion:

Dr. Naoki Harada demonstrates a clear trajectory of research excellence, grounded in scientific rigor and driven by impactful biomedical questions. His ability to identify molecular mechanisms (e.g., REDD2’s role in β-cell dysfunction) and propose therapeutic directions sets him apart as a leading academic in metabolic disease research. His publication record, industry collaborations, and professional memberships underscore a mature and influential academic career.